BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30161236)

  • 21. Prevalence of human papillomavirus types in cervical cancerous and precancerous lesions of Ecuadorian women.
    Mejía L; Muñoz D; Trueba G; Tinoco L; Zapata S
    J Med Virol; 2016 Jan; 88(1):144-52. PubMed ID: 26113443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.
    Fossum GH; Lie AK; Jebsen P; Sandlie LE; Mork J
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):4003-4010. PubMed ID: 28933005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.
    Reuschenbach M; Huebbers CU; Prigge ES; Bermejo JL; Kalteis MS; Preuss SF; Seuthe IM; Kolligs J; Speel EJ; Olthof N; Kremer B; Wagner S; Klussmann JP; Vinokurova S; von Knebel Doeberitz M
    Cancer; 2015 Jun; 121(12):1966-76. PubMed ID: 25731880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of human papillomavirus type 16 and its genetic variants with cervical lesion in Korea.
    Park JS; Shin S; Kim EC; Kim JE; Kim YB; Oh S; Roh EY; Yoon JH
    APMIS; 2016 Nov; 124(11):950-957. PubMed ID: 27546189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas.
    Kreimer AR; Clifford GM; Snijders PJ; Castellsagué X; Meijer CJ; Pawlita M; Viscidi R; Herrero R; Franceschi S;
    Int J Cancer; 2005 Jun; 115(2):329-32. PubMed ID: 15688391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular variants of HPV-16 associated with cervical cancer in Indian population.
    Pillai MR; Hariharan R; Babu JM; Lakshmi S; Chiplunkar SV; Patkar M; Tongaonkar H; Dinshaw K; Jayshree RS; Reddy BK; Siddiqui M; Roychoudury S; Saha B; Abraham P; Gnanamony M; Peedicayil A; Subhashini J; Ram TS; Dey B; Sharma C; Jain SK; Singh N
    Int J Cancer; 2009 Jul; 125(1):91-103. PubMed ID: 19358280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Human Papillomavirus as a Common Pathogen in Oropharyngeal, Anal and Cervical Cancers.
    Otter S; Whitaker S; Chatterjee J; Stewart A
    Clin Oncol (R Coll Radiol); 2019 Feb; 31(2):81-90. PubMed ID: 30385006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
    Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
    Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T
    Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers.
    Kondo S; Wakae K; Wakisaka N; Nakanishi Y; Ishikawa K; Komori T; Moriyama-Kita M; Endo K; Murono S; Wang Z; Kitamura K; Nishiyama T; Yamaguchi K; Shigenobu S; Muramatsu M; Yoshizaki T
    Oncogene; 2017 Mar; 36(12):1687-1697. PubMed ID: 27694899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Papillomavirus Genotypes and HPV16 E6/E7 Variants among Patients with Genital Cancers in Vietnam.
    Pham TTT; Bi X; Hoang HTT; Ishizaki A; Nguyen MTP; Nguyen CH; Nguyen HP; Pham TV; Ichimura H
    Jpn J Infect Dis; 2018 Nov; 71(6):419-426. PubMed ID: 29962490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mate pair sequencing of oropharyngeal squamous cell carcinomas reveals that HPV integration occurs much less frequently than in cervical cancer.
    Gao G; Johnson SH; Kasperbauer JL; Eckloff BW; Tombers NM; Vasmatzis G; Smith DI
    J Clin Virol; 2014 Mar; 59(3):195-200. PubMed ID: 24440282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between HPV 16, 18, 31, 33, 45 DNA detection and quantitation and E6/E7 mRNA detection among a series of cervical specimens with various degrees of histological lesions.
    Baron C; Henry M; Tamalet C; Villeret J; Richet H; Carcopino X
    J Med Virol; 2015 Aug; 87(8):1389-96. PubMed ID: 25908062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
    Berlin Grace VM
    Indian J Cancer; 2009; 46(3):203-7. PubMed ID: 19574671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx.
    Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM
    Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus type 16 variants in cervical cancer from an admixtured population in Brazil.
    Junes-Gill K; Sichero L; Maciag PC; Mello W; Noronha V; Villa LL
    J Med Virol; 2008 Sep; 80(9):1639-45. PubMed ID: 18649325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical status and expression of HPV genes in cervical cancers.
    Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
    Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus genotype as a major determinant of the course of cervical cancer.
    Lombard I; Vincent-Salomon A; Validire P; Zafrani B; de la Rochefordière A; Clough K; Favre M; Pouillart P; Sastre-Garau X
    J Clin Oncol; 1998 Aug; 16(8):2613-9. PubMed ID: 9704710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.